Mitogen activating protein kinases (MAPKs) families, including c-Jun N terminal kinases (JNK), extracellular signal-regulated kinase-1 (ERK1), and MAPK p38 highly expressed in prostate cancer that leads to activate numerous factors resulting in proliferation and invasion [6]. Here, MAPK3 is linked to prostate carcinoma.